Catabasis Pharmaceuticals, Inc. (CATB): Price and Financial Metrics
CATB Price/Volume Stats
| Current price | $8.54 | 52-week high | $47.82 |
| Prev. close | $9.18 | 52-week low | $6.31 |
| Day low | $8.46 | Volume | 98,800 |
| Day high | $9.21 | Avg. volume | 491,246 |
| 50-day MA | $9.82 | Dividend yield | N/A |
| 200-day MA | $13.56 | Market Cap | 33.34M |
CATB Stock Price Chart Interactive Chart >
Catabasis Pharmaceuticals, Inc. (CATB) Company Bio
Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics using its proprietary Safely Metabolized And Rationally Targeted, or SMART, linker technology platform. The company was incorporated in 2008 and is based in Cambridge, Massachusetts.
CATB Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | -71.30% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | 0.00% |
| 2020 | -63.79% |
| 2019 | 35.24% |
Loading social stream, please wait...